Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas

Aneuploidy is the hallmark of malignancy. Our previous study successfully detected nonhematogenic circulating aneuploidy cells (CACs) in types of gliomas. The current prospective clinical study aims to further precisely subcategorize aneuploid CACs, including CD31(−) circulating tumor cells (CTCs) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mingxiao, Gao, Faliang, Ren, Xiaohui, Dong, Gehong, Chen, Hongyan, Lin, Alexander Y., Wang, Daisy Dandan, Liu, Mingyang, Lin, Peter Ping, Shen, Shaoping, Jiang, Haihui, Yang, Chuanwei, Zhang, Xiaokang, Zhao, Xuzhe, Zhu, Qinghui, Li, Ming, Cui, Yong, Lin, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530864/
https://www.ncbi.nlm.nih.gov/pubmed/35940591
http://dx.doi.org/10.1111/cas.15516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530864/
https://www.ncbi.nlm.nih.gov/pubmed/35940591
http://dx.doi.org/10.1111/cas.15516

Ejemplares similares